...
首页> 外文期刊>Biomaterials >The margination propensity of ellipsoidal microanoparticles to the endothelium in human blood flow
【24h】

The margination propensity of ellipsoidal microanoparticles to the endothelium in human blood flow

机译:椭圆形纳米微粒在人血流中对内皮的边缘化倾向

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Particle shape is becoming increasingly recognized as an important parameter for the development of vascular-targeted carriers (VTCs) for disease treatment and diagnosis. However, limited research exists that investigates how particle shape coupled with hemodynamics affects VTC margination (localization and adhesion). In this study, we investigate the effects of particle shape parameters (volume, aspect ratio, axis length) on the margination efficacy of targeted spheres and prolate ellipsoids (rods) to an inflamed endothelial wall from human blood flow in an invitro model of human vasculature. Overall, particles with 2μm equivalent spherical diameters (ESD) display higher margination than particles with either 1μm or 500nm ESDs. Interestingly, rod-shaped microparticles (1μm or 2μm ESD) with high aspect ratios display significantly improved margination compared to spheres of equal volume, particularly under high shear rates and disturbed flow profiles. Nanorods (500nm ESD), even with high aspect ratio, do not display enhanced margination compared to that of equivalent spheres, which suggests that nanorods, like nanospheres, display minimal margination due to their inability to effectively localize to the vessel wall in the presence of RBCs.
机译:颗粒形状越来越被认为是开发用于疾病治疗和诊断的血管靶向载体(VTC)的重要参数。但是,有限的研究调查了颗粒形状与血液动力学如何影响VTC边缘化(定位和粘附)。在这项研究中,我们研究了在人体血管系统的体外模型中,颗粒形状参数(体积,长宽比,轴长)对目标球体和扁长椭球体(棒)从人血流向发炎的内皮壁的边缘化功效的影响。 。总体而言,具有2μm等效球直径(ESD)的颗粒比具有1μm或500nm ESD的颗粒具有更高的裕度。有趣的是,与等体积的球体相比,具有高长宽比的棒状微粒(1μm或2μmESD)显示出明显改善的边缘,特别是在高剪切速率和扰动的流动曲线下。与等效球体相比,纳米棒(500nm ESD)即使具有高的长宽比,也没有显示出增强的边缘化,这表明,纳米棒(如纳米球)由于在存在碳纳米管的情况下无法有效地定位于血管壁而显示出最小化的边缘化。红细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号